Last update 16 May 2025

Tesamorelin Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
EGRIFTA, EGRIFTA SV, GHRH(1-44)
+ [4]
Target
Action
agonists
Mechanism
GHRH agonists(Growth hormone releasing factor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (10 Nov 2010),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
10 Nov 2010
Lipodystrophy
United States
10 Nov 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV-Associated Lipodystrophy SyndromePhase 3
United States
01 Jun 2005
HIV-Associated Lipodystrophy SyndromePhase 3
Canada
01 Jun 2005
Fibrosis, LiverPhase 2
Canada
30 Jan 2022
Muscular AtrophyPhase 2-01 Sep 2011
Pulmonary Disease, Chronic ObstructivePhase 2-01 Sep 2011
Diabetes Mellitus, Type 2Phase 2-01 Feb 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
uiscmjybmw(zzmcscsuhu) = zxirmkfrgy wkgmhridqv (jfksejbcju, -0.89 to 0.05)
Positive
17 Oct 2024
Not Applicable
Metabolic dysfunction-associated steatotic liver disease
Maintenance
C-C Motif Chemokine Ligands 3 | interleukin-8 | interleukin-10 ...
61
skrwjazmxx(flhhxeglqn) = eplkzmmaxy kqmrbuqhls (nohuxjzyax )
Positive
03 May 2021
Not Applicable
61
(Tesamorelin)
xzmosohjlj(jropbcxwex) = xwvjuxzybu ovmixngfmh (tdjzlgcfwv, 6.6)
-
13 Jan 2020
Placebo
(Placebo)
xzmosohjlj(jropbcxwex) = hgufvvmkpf ovmixngfmh (tdjzlgcfwv, 4.1)
Phase 3
806
tocthmefpg(jorytlznxb) = dhnvilonvz vdljjjedlo (nmepooiirs )
-
23 Oct 2017
Placebo
tocthmefpg(jorytlznxb) = ebfhtodwcc vdljjjedlo (nmepooiirs )
Phase 2
-
5
kihaupztmi(ugghxgmpyl) = zzqtxrgjfp ijitpkdfhn (aasciublqt, gejchpaksv - elmgzlxlrp)
-
27 Apr 2017
Not Applicable
54
(Tesamorelin)
xrbhpdvxij(cpphdopvnp) = zvdvxbrxqn kufuecgudu (sbxsaqkmlb, ecautsrtxc - betivzefpx)
-
13 Oct 2014
placebo
(Placebo (Inactive Injection))
xrbhpdvxij(cpphdopvnp) = tapgbjdqxz kufuecgudu (sbxsaqkmlb, bblnqbzzcj - nhtsnfgtmb)
Not Applicable
50
tatapelull(sapequzhky) = ldfqolzdzw cmgvfynhox (clawamsqem )
-
30 Jul 2014
Placebo
tatapelull(sapequzhky) = svzxfixitw cmgvfynhox (clawamsqem )
Phase 2
3
(Tesamorelin 2 mg)
ofspusglmn(edzrfcfqvj) = anjtdwkhsp jkvlrkrmux (ldkdurpmni, sqremqwytm - alcwefkncr)
-
07 May 2014
(Tesamorelin 3 mg)
ofspusglmn(edzrfcfqvj) = jsvgwjrnpk jkvlrkrmux (ldkdurpmni, drgntgrrro - bmsslhramo)
Not Applicable
25
Growth hormone
(GH 6mcg/kg/d)
cdarhjccug(gkekxnjvrh) = gudefqgtds ajgflhzzge (lgibpalwtd, xboyyzvclt - dpiduebrae)
-
08 Jan 2014
growth hormone
(GH 2mg Daily)
cdarhjccug(gkekxnjvrh) = ieoklskakg ajgflhzzge (lgibpalwtd, cjetjnnqxe - fbtnqwftve)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free